Active Hexose Correlated Compound Activates Immune Function To
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Free PDF Download
WCRJ P.M. # 4308 WCRJ 2016; 3 (1): e652 POLYSACCHARIDE FROM LENTINUS EDODES FOR INTEGRATIVE CANCER TREATMENT: IMMUNOMODULATORY EFFECTS ON LYMPHOCYTE POPULATION A. DEL BUONO1, M. BONUCCI2, S. PUGLIESE3, A. D’ORTA4, M. FIORANELLI5 1MMG ASL CE, Caserta, Italy 2Integrative Oncology, Casa di Cura San Feliciano, Rome, Italy 3CETAC, Research Center, Caserta, Italy 4DD Clinic, Caserta, Italy 5Integrative Oncology, Università degli Studi “Guglielmo Marconi”, Rome, Italy Abstract – Background: Fungal alpha and β-glucans have been used as therapeutic support for thousands of years in Eastern culture. Lentinan, the backbone of β-(1, 3)-glucan with β-(1, 6) branch es, is the main ingredient purified from Shiitake mushrooms and has been approved as a biological response modifier for the treatment of gastric cancer in Japan. Active Hexose Correlated Compound (AHCC) is an alpha-glucan rich nutritional supplement derived from the mycelia of shii- take (Lentinula edodes) of the basidiomycete family of mushrooms, a popular integrative medicine in Japan. Lentinan may exert a synergistic action with anti-cancer monoclonal antibodies to modu- late complement systems activity through the way of antibody-dependent cellular cytotoxicity and complement dependent cytotoxicity. Patients and Methods: Seven subjects with adenocarcinoma diagnosis (pancreatic, lung, colorectal) were recruited, and treated with AHCC (3 g/die). Lymphocyte typing assays were performed by cytofluorometry (Abbott CELL-DYN Ruby) at start (T0) and after one month from AHCC administration (T1). Results: After one month, neutrophils increased from 41% to 54%; lymphocytes and monocytes decreased, respectively, from 45% to 30% and 10% to 1%; lymphocyte population relationships variations: CD3/CD4 increased from 16% to 30%, CD3/CD8 (suppressor) decreased from 53% to 24%; CD4/CD8 increased from 0.3% to 1.3%; CD3+/CD16+/CD56 Natural Killer (NK) cells increased from 113% to 151%; CD8/CD3 (suppressor/cytotoxic) increased from 3% to 5%. -
Αglucan (AHCC Compound Liquid Derived from Basidiomycetes) Contributes to Macrophage Activation More Than Βglucan ~ Promising Outlook for Tumor-Bearing Animals ~
αGlucan (AHCC Compound Liquid derived from Basidiomycetes) Contributes to Macrophage Activation More than βGlucan ~ Promising Outlook for Tumor-Bearing Animals ~ Takashi Nishizawa1), Koji Wakame2), Hiroshi Okawa3) 1) Kagawa University Faculty of Medicine 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa Prefecture, 761-0793, Japan 2) Amino Up Chemical Co., Ltd. HIGH-TECH HILL SHIN-EI 363-32 Shin-ei, Kiyota, Sapporo, 004-0839 Japan 3) Scarecrow Corporation Umeyama Bldg. 2F 11-8 Shinzen-cho Shibuya Tokyo 150-0045, Japan In recent years, more attention has been given to methods that enhance a host’s immunity through immunostimulatory substances as alternatives to surgery or anti-cancer drug for malignant growths (cancer) in small animals. We focused on AHCC, a basidiomycete-derived culture with an management, conducting experiments related to the immune Photo 1 system. First, we produced a liquid for small animals combining arginine, glutamine, nucleic acids (RNA, DNA), etc. with AHCC (Photo 1) to study the activation effects on macrophage (important role in tumor immunity) and lymphocytes. Since we believe the active component of AHCC to be α-glucan, we compared α-glucan with mushroom β-glucan activation, known for its general immune-boosting effects. Key words : AHCC Liquid, α-glucan, macrophage reports indicated the existence of α-1,4-glucan in which 2’- and What is AHCC o AHCC (Active Hexose Correlated Compound) is a plant of α-glucan is not simply an extract from basidiomycete culture, polysaccharide compound abundant in α-glucan extracted but rather stems from normal α-glucan being enzymatically from a mycelium culture solution of a basidiomycete from the Fig. -
AHCC) in the Management of Head & Neck Cancer Patients
International Journal of Clinical Medicine, 2011, 2, 588-592 doi:10.4236/ijcm.2011.25097 Published Online November 2011 (http://www.SciRP.org/journal/ijcm) Integrating Complimentary and Alternative Medicine in Form of Active Hexose Correlated Compound (AHCC) in the Management of Head & Neck Cancer Patients Dillip Kumar Parida1*, Koji Wakame2, Taisei Nomura3 1Department of Radiation Oncology, North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences, Shillong, India; 2Amino up Chemical Co. Ltd., Sapporo, Japan; 3National Institute of Biomedical Innovation, Osaka, Japan. Email: *[email protected] Received September 4th, 2011; revised October 17th, 2011; accepted October 26th, 2011. ABSTRACT Objectives: The Active Hexose Correlated Compound (AHCC), is produced from mushroom mycerium and rich in al- pha glucans was administered to the cancer patients along with chemotherapy to see if it is having any beneficial effects on the final outcome in terms of reducing side effects of chemotherapy, maintaining the general condition and having effect on tumor control. Methods: Twenty five patients were administered AHCC along with conventional palliative chemotherapy regimen out of which sixteen patients received paclitaxel, and cisplatinum/carboplatin, nine patients re- ceived combination of cisplatim and 5-Flurouracil. All the patients were having advance stage (T3/T4) head and neck cancers. Thirteen patients were cancer of cheek, followed by cancer of tongue (4), oro-pharyngeal cancer (6) and can- cer of naso-pharynx (2). Results: All the patients tolerated AHCC well with no added symptoms. Twenty patients re- ported that they are feeling stronger than before at the time of initiation of chemotherapy cycles. Almost all the patients reported to have better appetite after they started taking AHCC. -
The Effects of AHCC®, a Standardized Extract of Cultured Lentinura
Hindawi Journal of Immunology Research Volume 2019, Article ID 3758576, 7 pages https://doi.org/10.1155/2019/3758576 Review Article The Effects of AHCC®, a Standardized Extract of Cultured Lentinura edodes Mycelia, on Natural Killer and T Cells in Health and Disease: Reviews on Human and Animal Studies Min Sun Shin,1 Hong-Jai Park,1 Takahiro Maeda,2 Hiroshi Nishioka,2 Hajime Fujii,2 and Insoo Kang 1 1Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA 2Research and Development Division, Amino Up Co., Ltd., 004-0839 Sapporo, Japan Correspondence should be addressed to Insoo Kang; [email protected] Received 7 October 2018; Accepted 20 November 2019; Published 20 December 2019 Academic Editor: Paola Nistico Copyright © 2019 Min Sun Shin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Mushrooms have been used for various health conditions for many years by traditional medicines practiced in different regions of the world although the exact effects of mushroom extracts on the immune system are not fully understood. AHCC® is a standardized extract of cultured shiitake or Lentinula edodes mycelia (ECLM) which contains a mixture of nutrients including oligosaccharides, amino acids, and minerals obtained through liquid culture. AHCC® is reported to modulate the numbers and functions of immune cells including natural killer (NK) and T cells which play important roles in host defense, suggesting the possible implication of its supplementation in defending the host against infections and malignancies via modulating the immune system. -
Effect of Active Hexose Correlated Compound (AHCC) in Alcohol-Induced Liver Enzyme Elevation
J Nutr Sci Vitaminol, 60, 348–356, 2014 Effect of Active Hexose Correlated Compound (AHCC) in Alcohol-Induced Liver Enzyme Elevation Hyangkyoung KIM1, Jung-Ha KIM2,* and Jee-Aee IM3 1 Department of Surgery, and 2 Department of Family Medicine, Chung-Ang University Healthcare System, Chung-Ang University College of Medicine, 221 Heukseok-dong, Dongjak-gu, 156–756, Seoul, Korea 3 Sports and Medicine Research Center, INTOTO Inc., 401 Dawoo BD, 90–6 Daeshin-Dong, Seodaemun-Gu, Seoul, Korea (Received March 17, 2014) Summary To investigate the effects of Active Hexose Correlated Compound (AHCC) supplementation and the mechanism action of AHCC in patients with alcohol-induced mildly elevated liver enzyme levels, participants were randomly allocated to the placebo, 1 g AHCC, or 3 g AHCC group and took the supplement for 12 wk. Subjects visited the hospital for clinical and biochemical measurements, for examination of adverse events, to return unused supplements, and to obtain their next supplements. Biochemical tests including liver enzymes, a questionnaire survey, and anthropometric measurements were collected at baseline and every 4 wk thereafter. Adherence and adverse events were evaluated. After 12 wk of supplementation, the percentage change in alanine aminotransferase (ALT) level was significantly different between the placebo (4.02659.07%) and both AHCC groups (1 g AHCC: 223.89620.59%, 3 g AHCC: 224.09630.73%) (p50.04). Serum levels of tumor necrosis factor-a (p,0.05) and interleukin-1b (p,0.01) were significantly lower, while those of adiponectin were higher in both AHCC groups than in the placebo group (p,0.01). -
Combining the Anticancer and Immunomodulatory Effects of Astragalus and Shiitake As an Integrated Therapeutic Approach
nutrients Opinion Combining the Anticancer and Immunomodulatory Effects of Astragalus and Shiitake as an Integrated Therapeutic Approach Biju Balakrishnan 1,2 , Qi Liang 1,3,† , Kevin Fenix 2,4,† , Bunu Tamang 1, Ehud Hauben 2,4,5,*, Linlin Ma 6,* and Wei Zhang 1,* 1 Centre for Marine Bioproducts Development, College of Medicine & Public Health, Flinders University, Bedford Park, Adelaide, SA 5042, Australia; [email protected] (B.B.); qi.liang@flinders.edu.au (Q.L.); tama0054@flinders.edu.au (B.T.) 2 The Basil Hetzel Institute for Translational Health Research, Adelaide, SA 5011, Australia; [email protected] 3 Shanxi University of Traditional Chinese Medicine, Taiyuan 030600, China 4 Discipline of Surgery, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA 5000, Australia 5 AusHealth Corporate Pty Ltd., Adelaide, SA 5032, Australia 6 Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia * Correspondence: [email protected] (E.H.); linlin.ma@griffith.edu.au (L.M.); wei.zhang@flinders.edu.au (W.Z.); Tel.: +61-88132-7450 (E.H.); +61-7-3735-4175 (L.M.); +61-8-7221-8557 (W.Z.) † These authors contributed equally to this work. Abstract: Astragalus root (Huang Qi) and Shiitake mushrooms (Lentinus edodes) are both considered medicinal foods and are frequently used in traditional Chinese medicine due to their anticancer and immunomodulating properties. Here, the scientific literatures describing evidence for the anticancer and immunogenic properties of Shiitake and Astragalus were reviewed. Based on our experimental Citation: Balakrishnan, B.; Liang, Q.; data, the potential to develop medicinal food with combined bioactivities was assessed using Shiitake Fenix, K.; Tamang, B.; Hauben, E.; mushrooms grown over Astragalus beds in a proprietary manufacturing process, as a novel cancer Ma, L.; Zhang, W. -
Best of Naturopathy Belanger Townsend Letter
Best of Naturopathy An In-Office Evaluation of Four Dietary Supplements on Natural Killer Cell Activity by James Belanger, ND, MT Abstract: Introduction NK cell activity level. Several studies have The natural Despite recent advances in oncology, a demonstrated improved survival rates killer (NK) cell substantial amount of people with cancer after activated killer cells are transferred activity blood are dying in less than five years (See into cancer patients. Transplanting 1 test is useful in predicting the prognosis table 1). activated killer cells into people, however, of a cancer patient. The purpose of this To help improve these survival rates it may create unwanted side effects,23,24 in-office, nonrandomized open-label trial may be important to identify and correct therefore, activating the natural killer was to determine whether four different various adverse prognostic indicators. cells via an oral route may be a better dietary supplements commonly sold in One negative prognostic indicator is low choice. Various natural substances such health food stores and over the Internet, natural killer (NK) cell activity. Natural as coriolus mushroom, active hexose consistently and statistically affected NK killer cells comprise between 5–20% of correlated compound (AHCC), modified cell activity in cancer patients. Thirty-four the peripheral blood lymphocytes and are arabinoxylane and antigen-infused patients were assigned to one of four capable of recognizing and killing tumor dialyzable bovine colostrum/whey extract groups: Group A was given 1-3g/day of cells that completely lack expression of have been described as oral NK cell modified arabinoxylane with meals. Group MHC Class I and II antigens.2 The ability activators in articles and advertisements. -
Attenuation of Pulmonary Mycobacterium Avium Disease By
al Dis ion ord rit e t rs u N & f T o h l e a r Fujita et al., J Nutr Disorders Ther 2015, 5:4 n a r p u y o Journal of Nutritional Disorders & Therapy DOI: 10.4172/2161-0509.1000174 J ISSN: 2161-0509 Research Article Open Access Attenuation of Pulmonary Mycobacterium Avium Disease by Active Hexose Correlated Compound (AHCC) in Mice Masaki Fujita1*, Takemasa Matsumoto1, Ryosuke Hirano1, Kazunari Ishii2, Kenji Hiromatsu2, Junji Uchino1 and Kentaro Watanabe1 1Department of Respiratory Medicine, Faculty of Medicine, Fukuoka University, Japan 2Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Japan Abstract Introduction: Pulmonary Mycobacterium avium disease is a chronic and progressive disease that is known to be difficult to treat. Active hexose correlated compound (AHCC) is an extract obtained by culturing mycelia of Basidiomycota. AHCC is reported to attenuate several experimental animal infection models. We hypothesized that AHCC could attenuate pulmonary M. avium disease in mice. Methods: Mycobacterium avium (108 cfu/head) was administered intratracheally into mice (C57/BL6). Infected mice were supplied with 1,000 mg/kg/day of AHCC by oral administration until euthanasia. The mice were sacrificed at seven days later or 21 days later after M. avium infection. The lung homogenates were cultured on Middlebrook 7H10 agar plates for bacterial colony counts. Additionally, the number of inflammatory cells in the lungs was analyzed by FACS. Tissue sections of the lungs were stained by hematoxylin and eosin or Ziehl-Neelsen methods. In addition, the number of bacterial colonies in the macrophages was counted in vitro. -
Long-Term Administration of Active Hexose Correlated Compound As A
Integrative Cancer Science and Therapeutics Case Report ISSN: 2056-4546 Long-term administration of Active Hexose Correlated Compound as a dietary supplement to a patient after breast cancer surgery and chemotherapy: A case report Koji Wakame1*, Jun Takanari2, Atsuya Sato2, Satomi Shirakawa2 and Ken-ichi Komatsu1 1Department of Pharmacology, Hokkaido Pharmaceutical University School of Pharmacy, Japan 2Science and Development Group, Amino Up Chemical Co. Ltd. , Japan Abstract Active Hexose Correlated Compound (AHCC) is a dietary supplement obtained by long-term liquid culturing of shiitake mycelia. AHCC has various biological functions; in particular, its immune stimulating effect is well known. In recent years, the use of patients for treatment of cancer is increasing in the field of integrated medical care under the initiative of doctors and other paramedic experts. Practically, AHCC research from both animal models and human clinical trials has been reported, but an insufficient number of individual cases have been reported. Therefore, we report the case of a breast cancer patient who took AHCC (3 g/day) for 9 years following breast cancer surgery and chemotherapy treatment. Results indicated no cancer recurrence during the period of AHCC consumption and no rise of tumor markers (CEA, CA 15-3); further, good quality of life was maintained. Further, there were no reports of adverse reactions thought to be caused by AHCC. In sum, we report a case in which a patient ingested AHCC for almost a decade after breast cancer surgery, maintaining good health status. Abbreviations: AHCC: Active Hexose Correlated Compound, quality of life. CEA: Carcinoembryonic Antigen, CA15-3: Carbohydrate antigen 15- 3, QOL: Quality of Life Case presentation Patient: Born in 1963, female, Irish, (53 years old as of 2017). -
(Grifola Frondosa) and Shiitake (Lentinula Edodes) Extracts
Original Article Page 1 of 6 Immune-enhancing effects of Maitake (Grifola frondosa) and Shiitake (Lentinula edodes) extracts Vaclav Vetvicka, Jana Vetvickova University of Louisville, Department of Pathology, Louisville, KY, USA All authors contributed equally. Corresponding to: Dr. Vaclav Vetvicka. University of Louisville, Department of Pathology, 511 S. Floyd, Louisville, KY 40202, USA. Email: [email protected]. Background: The role of glucan in stimulation of immune reactions has been studied for several decades. In this report, we focused on the effects of orally administered glucan Maitake and Shiitake on immune reactions. Materials and methods: We measured phagocytosis, NK cell activity, and secretion of IL-6, IL-12, IFN-γ as well as C-reactive protein (CRP) after 14 days of oral application of tested glucans. For comparison, active hexose correlated compound (AHCC) was used in all reactions. Results: We found significant stimulation of defense reaction. In all cases, the most active was the Maitake- Shiitake combination, with Maitake alone being the second strongest, followed by Shiitake on its own and AHCC. Conclusions: Short-term oral application of natural immunomodulating glucans from Maitake and Shiitake mushrooms strongly stimulated both the cellular and humoral branch of immune reactions. These activities were significantly higher than those of AHCC. Keywords: Phagocytosis; cytokines; NK cells; C-reactive protein (CRP); glucan Submitted Jan 21, 2014. Accepted for publication Feb 21, 2014. doi: 10.3978/j.issn.2305-5839.2014.01.05 Scan to your mobile device or view this article at: http://www.atmjournal.org/article/view/3394/4245 Introduction from Saccharomyces cerevisiae. Initial glucan research led to the discovery of glucan’s Natural products have been used to help treat and/ ability to stimulate the phagocytic system, enhance general or prevent diseases throughout man’s history. -
AHCC Published Research
Food Chemistry 136 (2013) 1288–1295 Contents lists available at SciVerse ScienceDirect Food Chemistry journal homepage: www.elsevier.com/locate/foodchem The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-jB/MAPK activation Abdelali Daddaoua a, Enrique Martínez-Plata b, Mercedes Ortega-González c, Borja Ocón d, Carlos J. Aranda c, Antonio Zarzuelo d, María D. Suárez c, Fermín Sánchez de Medina d, ⇑ Olga Martínez-Augustin c, a Department of Environmental Protection, Consejo Superior de Investigaciones Científicas, C/ Profesor Albareda 1, E-18008 Granada, Spain b Pharmacy Department, Hospital de Poniente, El Ejido, Almería, Spain c Department of Biochemistry and Molecular Biology II, CIBERehd, School of Pharmacy, University of Granada, Granada, Spain d Department of Pharmacology, CIBERehd, School of Pharmacy, University of Granada, Granada, Spain article info abstract Article history: Active Hexose Correlated Compound (AHCC) is an immunostimulatory nutritional supplement. AHCC Received 29 May 2012 effects and mechanism of action on intestinal epithelial cells or monocytes are poorly described. AHCC Received in revised form 31 July 2012 was added to the culture medium of intestinal epithelial cells (IEC18 and HT29 cells) and monocytes Accepted 5 September 2012 (THP-1 cells) and assessed the secretion of proinflammatory cytokines by ELISA. Inhibitors of NFjB Available online 23 September 2012 and MAPKs were used to study signal transduction pathways while TLR4 and MyD88 were silenced in IEC18 cells using shRNA. It was found that AHCC induced GROa and MCP1 secretion in IEC18 and IL-8 Keywords: in HT29 cells. -
AHCC on Immune Response in Patients Receiving Platinum Based Chemotherapy
DOI:10.22034/APJCP.2017.18.3.633 AHCC on Immune Response in Patients Receiving Platinum Based Chemotherapy RESEARCH ARTICLE The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy Wineeya Suknikhom, Ruangsak Lertkhachonsuk, Tarinee Manchana* Abstract Background: Adjuvant chemotherapy is a required treatment for most patients with epithelial ovarian cancer (EOC) or peritoneal cancer. However, it has many adverse events which may affect oncologic outcomes. Active hexose correlated compound (AHCC) has been reported to be an immunoenhancer to decrease adverse events of chemotherapy. Materials and Methods: Patients were randomized and allocated to receive either AHCC three grams/day (500mg/ capsule) or placebo. These drugs were administrated as two capsules orally three times a day throughout six cycles of chemotherapy. The primary outcome was a change of CD4+ and CD8+ T cell lymphocytes in peripheral blood samples from baseline to completion of chemotherapy. Secondary outcomes were rate of bone marrow suppression, adverse events and quality of life (QOL) as assessed by Thai version of the Functional Assessment of Cancer Therapy-General (FACT-G). Results: Study outcomes were analyzed in 28 patients, 14 patients in each group. Changes in CD4+ and CD8+ T cell lymphocytes levels were not significantly different between AHCC and placebo group; 43.5/ul (-237.5, 143.3) versus -69.5 /ul (-223.8, 165) for CD4+ level, p=0.61 and 49.5.0 /ul (-80, 153.3) versus 4.0 /ul (-173, 62.5) for CD8+ level, p=0.19.